Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, nine have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $98.75.
A number of analysts recently weighed in on the stock. Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th.
View Our Latest Report on GE HealthCare Technologies
Institutional Investors Weigh In On GE HealthCare Technologies
GE HealthCare Technologies Stock Down 0.4 %
Shares of NASDAQ GEHC opened at $82.14 on Wednesday. GE HealthCare Technologies has a 52-week low of $74.51 and a 52-week high of $94.80. The firm has a fifty day moving average of $87.25 and a 200-day moving average of $86.10. The stock has a market capitalization of $37.56 billion, a PE ratio of 18.97, a P/E/G ratio of 3.19 and a beta of 1.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. On average, analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- The Significance of Brokerage Rankings in Stock Selection
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- P/E Ratio Calculation: How to Assess Stocks
- 3 Must-Own Stocks to Build Wealth This Decade
- ESG Stocks, What Investors Should Know
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.